Works matching IS 14363291 AND DT 2019 AND VI 22 AND IP 2
Results: 19
Clinical advantages of robotic gastrectomy for clinical stage I/II gastric cancer: a multi-institutional prospective single-arm study.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 377, doi. 10.1007/s10120-018-00906-8
- By:
- Publication type:
- Article
Correction to: Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 421, doi. 10.1007/s10120-019-00925-z
- By:
- Publication type:
- Article
Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 245, doi. 10.1007/s10120-018-0901-3
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Mutation heterogeneity between primary gastric cancers and their matched lymph node metastases.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 323, doi. 10.1007/s10120-018-0870-6
- By:
- Publication type:
- Article
Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 369, doi. 10.1007/s10120-018-0875-1
- By:
- Publication type:
- Article
Downregulation of miR-142-5p promotes tumor metastasis through directly regulating CYR61 expression in gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 302, doi. 10.1007/s10120-018-0872-4
- By:
- Publication type:
- Article
Clinicopathological differences in signet ring cell adenocarcinoma between early and advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 255, doi. 10.1007/s10120-018-0860-8
- By:
- Publication type:
- Article
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 273, doi. 10.1007/s10120-018-0859-1
- By:
- Publication type:
- Article
ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 287, doi. 10.1007/s10120-018-0866-2
- By:
- Publication type:
- Article
Potential for local resection with sentinel node basin dissection for early gastric cancer based on the distribution of primary sites.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 386, doi. 10.1007/s10120-018-0865-3
- By:
- Publication type:
- Article
A randomized controlled trial of postoperative intravenous acetaminophen plus thoracic epidural analgesia vs. thoracic epidural analgesia alone after gastrectomy for gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 392, doi. 10.1007/s10120-018-0863-5
- By:
- Publication type:
- Article
Solid-type poorly differentiated adenocarcinoma of the stomach: clinicopathological and molecular characteristics and histogenesis.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 314, doi. 10.1007/s10120-018-0862-6
- By:
- Publication type:
- Article
Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 355, doi. 10.1007/s10120-018-0861-7
- By:
- Publication type:
- Article
CD44<sup>+</sup> cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 264, doi. 10.1007/s10120-018-0858-2
- By:
- Publication type:
- Article
Endoscopic submucosal dissection for papillary adenocarcinoma of the stomach: low curative resection rate but favorable long-term outcomes after curative resection.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 363, doi. 10.1007/s10120-018-0857-3
- By:
- Publication type:
- Article
Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 413, doi. 10.1007/s10120-018-0856-4
- By:
- Publication type:
- Article
Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 403, doi. 10.1007/s10120-018-0854-6
- By:
- Publication type:
- Article
Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 335, doi. 10.1007/s10120-018-0853-7
- By:
- Publication type:
- Article